BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9266200)

  • 1. Pulmonary thrombo-embolism in nephrotic syndrome treated with tissue plasminogen activator.
    Reid CJ; Segal T
    Eur J Pediatr; 1997 Aug; 156(8):647-9. PubMed ID: 9266200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary thrombo-embolism in the nephrotic syndrome.
    Jones CL; Hébert D
    Pediatr Nephrol; 1991 Jan; 5(1):56-8. PubMed ID: 2025540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rt-PA thrombolysis in the treatment of massive pulmonary embolism].
    Van Hover P; Stockx L; Raat H; Vervloessem I; Vandenbosch G; Verhaeghe R; Baert AL
    J Belge Radiol; 1996 Nov; 79(5):208-10. PubMed ID: 8984107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of successful application of tissue plasminogen activator actilyse in complex intensive therapy for massive pulmonary artery embolism].
    Mierbekov EM; Artykbaev ZhT; Potseluev DD
    Anesteziol Reanimatol; 2004; (2):67-70. PubMed ID: 15206285
    [No Abstract]   [Full Text] [Related]  

  • 5. First trimester use of recombinant tissue plasminogen activator in pulmonary embolism.
    Huang WH; Kirz DS; Gallee RC; Gordey K
    Obstet Gynecol; 2000 Nov; 96(5 Pt 2):838. PubMed ID: 11094230
    [No Abstract]   [Full Text] [Related]  

  • 6. Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction.
    Meneveau N; Schiele F; Vuillemenot A; Valette B; Grollier G; Bernard Y; Bassand JP
    Eur Heart J; 1997 Jul; 18(7):1141-8. PubMed ID: 9243149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibrinolytic treatment of thrombus of the right atrium causing severe pulmonary embolism].
    Bardají A; Castander D; Guarinos J; Ridao C; Richart C
    Rev Esp Cardiol; 1998 Jan; 51(1):78-80. PubMed ID: 9522614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotic syndrome and pulmonary artery thrombosis.
    Ahmed K; Saeed E
    Am J Nephrol; 1995; 15(3):274-6. PubMed ID: 7618656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolysis in acute pulmonary embolism: to whom, how much and how?
    Jezek V
    Eur Heart J; 1997 Jul; 18(7):1045. PubMed ID: 9243132
    [No Abstract]   [Full Text] [Related]  

  • 10. High dose urokinase against massive pulmonary embolism in nephrotic syndrome.
    Chen G; Liu Y; Xie Y; Li J; Liu H; Sun L; Peng Y; Liu F
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):439-43. PubMed ID: 23386277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary microthrombi during left ventricular assist device implantation.
    Gregoric ID; Patel V; Radovancevic R; Bracey AW; Radovancevic B; Frazier OH
    Tex Heart Inst J; 2005; 32(2):228-31. PubMed ID: 16107123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Local fibrinolysis in massive pulmonary thromboembolism].
    Garro P; Ruiz J; Gener J; Muixart J
    Med Clin (Barc); 1996 Mar; 106(9):354. PubMed ID: 8667703
    [No Abstract]   [Full Text] [Related]  

  • 13. Massive pulmonary embolism: treatment with thrombus fragmentation and local fibrinolysis with recombinant human-tissue plasminogen activator.
    Stock KW; Jacob AL; Schnabel KJ; Bongartz G; Steinbrich W
    Cardiovasc Intervent Radiol; 1997; 20(5):364-8. PubMed ID: 9271647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mobile thrombus in the right atrium and pulmonary embolism: efficacy of thrombolytic treatment with alteplase].
    López-Haldón JE; Varela Aguilar JM; Martínez Martínez A; González de la Puente MA
    Med Clin (Barc); 1997 Feb; 108(5):198. PubMed ID: 9091727
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of a pulmonary embolism with low dose of tissue plasminogen activator after thoracic surgery.
    Shen L; Li Y; Hernandez-Arenas LA; Jiang G; Yang J
    Am J Emerg Med; 2016 Nov; 34(11):2259.e5-2259.e6. PubMed ID: 27266329
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary embolism thrombolysis: Do we need another agent?
    Goldhaber SZ
    Am Heart J; 1999 Jul; 138(1 Pt 1):1-2. PubMed ID: 10385751
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?
    Dalen JE; Alpert JS; Hirsh J
    Arch Intern Med; 1997 Dec 8-22; 157(22):2550-6. PubMed ID: 9531222
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thrombosis of superior longitudinal sinus and pulmonary embolism in nephrotic syndrome].
    Delmas MC; Cochat P; Ranchin B; Négrier C; Barre P; Bouvier R; David L
    Pediatrie; 1992; 47(1):31-5. PubMed ID: 1337773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary embolism associated with nephrotic syndrome in children: a preliminary report of 8 cases.
    Huang J; Yang J; Ding J
    Chin Med J (Engl); 2000 Mar; 113(3):251-3. PubMed ID: 11775257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator as an alternative to vena cava interruption in recurrent pulmonary thromboembolism.
    Hunker FD; Mason RE; Browne SD
    South Med J; 1990 Nov; 83(11):1305-6. PubMed ID: 2122525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.